![\"\"\/](\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/04\/ex99-1_001.jpg\")
<\/p>\n\u00a0<\/p>\n
\u00a0<\/p>\n
UNITED
\nSTATES<\/p>\n
SECURITIES
\nAND EXCHANGE COMMISSION\u00a0<\/p>\n
Washington,
\nD.C. 20549<\/p>\n
\u00a0<\/p>\n
FORM
\n6-K<\/p>\n
\u00a0<\/p>\n
REPORT
\nOF FOREIGN PRIVATE ISSUER<\/p>\n
PURSUANT
\nTO RULE 13a-16 OR 15d-16<\/p>\n
UNDER
\nTHE SECURITIES EXCHANGE ACT OF 1934<\/p>\n
\u00a0<\/p>\n
For
\nthe month of April 2026<\/p>\n
\u00a0<\/p>\n
Commission
\nFile Number: 001-42915<\/p>\n
\u00a0<\/p>\n
Alps
\nGroup Inc<\/p>\n
(Registrant\u2019s
\nName)<\/p>\n
\u00a0<\/p>\n
Unit
\nE-18-01 & E-18-02, Level 18, Icon Tower (East)<\/p>\n
No.
\n1, Jalan 1\/68F, Jalan Tun Razak<\/p>\n
50400
\nKuala Lumpur<\/p>\n
Wilayah
\nPersekutuan, Malaysia<\/p>\n
(Address
\nof Principal Executive Offices)<\/p>\n
\u00a0<\/p>\n
Indicate
\nby check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.<\/p>\n
\u00a0<\/p>\n
Form
\n20-F \u2612 Form 40-F \u2610<\/p>\n
\u00a0<\/p>\n
Indicate
\nby check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): \u2610<\/p>\n
\u00a0<\/p>\n
Indicate
\nby check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): \u2610<\/p>\n
\u00a0<\/p>\n
\u00a0<\/p>\n
\u00a0<\/p>\n
Appointment of Board Member<\/p>\n
\u00a0<\/p>\n
The
\nboard of directors (\u201cBoard\u201d) of Alps Group Inc ( \u201cCompany\u201d) announces that Mr. Hee H. Lee (\u201cMr.
\nLee\u201d) has been appointed as a director of the Company, effective April 17, 2026. In connection with the appointment,
\nthe number of members of the Board will increase from five (5) to six (6). Mr. Lee is independent pursuant to applicable Nasdaq rules.<\/p>\n
\u00a0<\/p>\n
Mr.
\nLee has over 30 years of experience in the financial services sector. He served as a Partner at Ernst & Young LLP from July 2013
\nto June 30, 2025, during which period he established and led the Americas Financial Accounting Advisory Services practice.
\nIn addition, he served as an advisor to the International Swaps and Derivatives Association for more than 20 years.<\/p>\n
\u00a0<\/p>\n
Mr.
\nLee holds a Master of Accountancy and Financial Information Systems from Cleveland State University and a Bachelor of Business Administration
\nfrom the University of Louisiana at Lafayette. He is a Certified Public Accountant licensed in the State of New York.<\/p>\n
\u00a0<\/p>\n
The
\nBoard believes Mr. Lee will bring abroad extensive and relevant professional experience to the Company. Mr. Lee is expected to serve
\nas a member of both the Audit Committee and the Compensation Committee of the Board.<\/p>\n
\u00a0<\/p>\n
The
\nCompany issued a press release on April 17, 2026 announcing the appointment of the director, and is furnished as Exhibit 99.1.<\/p>\n
\u00a0<\/p>\n
\u00a0<\/p>\n
Exhibits<\/p>\n
\u00a0<\/p>\n
Exhibit
\n No.
\n \u00a0
\n Description<\/p>\n
99.1*
\n \u00a0
\n Press Release dated April 17, 2026<\/p>\n
\u00a0<\/p>\n
\u00a0<\/p>\n
SIGNATURES<\/p>\n
\u00a0<\/p>\n
Pursuant
\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
\nthe undersigned, thereunto duly authorized.<\/p>\n
\u00a0<\/p>\n
\u00a0
\n Alps Group Inc<\/p>\n
\u00a0
\n \u00a0
\n \u00a0<\/p>\n
Date:
\n April 17, 2026
\n By:
\n \/s\/
\n Dr. Tham Seng Kong<\/p>\n
\u00a0
\n Name:
\n Dr.
\n Tham Seng Kong<\/p>\n
\u00a0
\n Title:
\n Chief
\n Executive Officer and Director<\/p>\n
\u00a0<\/p>\n
\u00a0<\/p>\n
\u00a0<\/p>\n
Exhibit
\n99.1<\/p>\n
\u00a0<\/p>\n
<\/p>\n
\u00a0<\/p>\n
Alps
\nGroup Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight<\/p>\n
\u00a0<\/p>\n
KUALA
\nLUMPUR, Malaysia, April 17, 2026 – Alps Group Inc (the \u201cCompany\u201d or \u201cAlps Group\u201d), the parent company
\nof Alps Life Sciences Inc. (\u201cAlps Holdco\u201d), a biotechnology research and healthcare platform focused on predictive,
\npreventive, and precision medicine, announced the appointment of Mr. Hee H. Lee (\u201cMr. Lee\u201d) to its Board of Directors
\n(the \u201cBoard\u201d), effective April 17, 2026. The Company\u2019s Board will increase from five (5) to six (6) directors
\nin connection with this appointment. Mr. Lee is considered independent under applicable Nasdaq rules and is expected to serve as a member
\nof the Audit Committee and the Compensation Committee.<\/p>\n
\u00a0<\/p>\n
Mr.
\nLee has over 35 years of experience in the public accounting and advisory services, including his tenure as a Partner at Ernst &
\nYoung LLP (\u201cEY\u201d) within its Global Financial Services Organization. During his career, Mr. Lee advised boards of directors
\nand senior management of financial institutions on financial reporting, corporate governance, structured transactions, and capital markets
\nmatters.<\/p>\n
\u00a0<\/p>\n
At
\nEY, Mr. Lee established and led the Americas Financial Accounting Advisory Services (\u201cFAAS\u201d) practice within the financial
\nservices sector. His experience spans asset management, banking, insurance, private equity, and fintech\/digital assets. He has advised
\non derivatives, securitization, structured financing, initial public offerings, and mergers and acquisitions, and served for more than
\n20 years as an advisor to the International Swaps and Derivatives Association (\u201cISDA\u201d), contributing to the development
\nand interpretation of industry standards affecting global capital markets.<\/p>\n
\u00a0<\/p>\n
Mr.
\nLee is a Certified Public Accountant licensed in the State of New York and a member of the American Institute of Certified Public Accountants.
\nHe holds a Master of Accountancy and Financial Information Systems from Cleveland State University and a Bachelor of Business Administration
\nfrom the University of Louisiana at Lafayette. He has also completed executive education programs in board and leadership development
\nat Harvard University and the Kellogg School of Management.<\/p>\n
\u00a0<\/p>\n
\u201cMr.
\nLee\u2019s experience in financial reporting, governance, and capital markets will strengthen the Board\u2019s oversight and support
\nthe Company\u2019s ongoing development as a public company,\u201d said Dr. Tham Seng Kong, Chief Executive Officer of Alps Group.<\/p>\n
\u00a0<\/p>\n
\u201cI
\nam pleased to join the Board of Alps Group Inc and look forward to contributing to the Company\u2019s strategic direction and governance
\nframework. The Company\u2019s focus on healthcare innovation is aligned with my professional and personal interests, and I look forward
\nto working with the Board and management team.\u201d said Mr. Lee.<\/p>\n
\u00a0<\/p>\n
\u00a0<\/p>\n
<\/p>\n
\u00a0<\/p>\n
About
\nAlps Group<\/p>\n
\u00a0<\/p>\n
Alps
\nGroup Inc is the parent company of Alps Life Sciences Inc., an integrated biotechnology platform integrating research and development,
\nmedical services, and wellness solutions of advanced therapies under one unified ecosystem aimed at improving healthcare outcomes globally.
\nAlps Group\u2019s mission is to create a fair healthcare ecosystem, to make advance predictive, preventive, and precision medicine accessible
\nand affordable.<\/p>\n
\u00a0<\/p>\n
Forward-Looking
\nStatements<\/p>\n
\u00a0<\/p>\n
Certain
\nstatements in this press release may be considered to contain certain \u201cforward-looking statements\u201d within the meaning of
\n\u201csafe harbor\u201d provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified
\nby words such as: \u201ctarget,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201cwill,\u201d \u201cshall,\u201d \u201cmay,\u201d
\n\u201canticipate,\u201d \u201cestimate,\u201d \u201cwould,\u201d \u201cpositioned,\u201d \u201cfuture,\u201d \u201cforecast,\u201d
\n\u201cintend,\u201d \u201cplan,\u201d \u201cproject\u201d and other similar expressions that predict or indicate future events
\nor trends or that are not statements of historical matters. Forward-looking statements are neither historical facts nor assurances of
\nfuture performance. Instead, they are based only on the Company management\u2019s current beliefs, expectations, and assumptions. Because
\nforward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that
\nare difficult to predict and many of which are outside of our control. Actual results and outcomes may differ materially from those indicated
\nin the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.<\/p>\n
\u00a0<\/p>\n
A
\nfurther list and description of risks and uncertainties can be found in documents filed with the Securities and Exchange Commission (\u201cSEC\u201d)
\nby the Company and other documents that we may file or furnish with the SEC, which you are encouraged to read. Any forward-looking statement
\nmade by us in this press release is based only on information currently available to the Company and speaks only as of the date on which
\nit is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may
\nbe made from time to time, whether as a result of new information, future developments, or otherwise, except as required by law.<\/p>\n
\u00a0<\/p>\n
Investor
\nRelations Contact<\/p>\n
\u00a0<\/p>\n
Alps
\nGroup Inc<\/p>\n
Email:
\ninvestorrelations@alpsmedical.com<\/p>\n
\u00a0<\/p>\n
\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"\u00a0 \u00a0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION\u00a0 Washington, D.C. 20549 \u00a0 FORM 6-K \u00a0 REPORT OF FOREIGN…\n","protected":false},"author":2,"featured_media":50690,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[50,15288,28941,336,28198,16149,3111,28970,28935,28969],"class_list":{"0":"post-50689","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-alps","8":"tag-alps","9":"tag-alps-group","10":"tag-audit-committee","11":"tag-biotechnology","12":"tag-board-appointment","13":"tag-compensation-committee","14":"tag-corporate-governance","15":"tag-ernst-young-partner","16":"tag-hee-h-lee","17":"tag-independent-director"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116420727588815398","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/50689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=50689"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/50689\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/50690"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=50689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=50689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=50689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}